Evaluation and Management of Low MCV, MCH, and MCHC
In an adult with low MCV, MCH, and MCHC (microcytic hypochromic anemia), iron deficiency is the most likely cause and should be confirmed with serum ferritin as the first-line diagnostic test, followed by oral iron replacement as initial therapy. 1
Diagnostic Approach
Initial Laboratory Evaluation
Serum ferritin is the single most useful marker for diagnosing iron-deficiency anemia, with a level <15 µg/L being 99% specific for true deficiency. 1 However, ferritin <45 µg/L provides optimal diagnostic balance (92% specificity) and should trigger further investigation, particularly when inflammation may be present. 1
Mean cell hemoglobin (MCH) is more reliable than MCV because it remains less affected by specimen storage and stays abnormal in both absolute and functional iron deficiency. 1 This makes the combination of low MCH with low MCV particularly useful for identifying iron-related disorders.
Differential Diagnosis Framework
The primary causes of microcytic anemia include:
- Iron deficiency anemia (most common): Nutritional deficiency, blood loss from gastrointestinal disease, malabsorption 2
- Thalassemia syndromes: Characterized by MCV disproportionately reduced relative to anemia severity 1
- Anemia of chronic disease (severe cases) 2
- Genetic disorders of iron metabolism or heme synthesis: Suggested by elevated ferritin/transferrin saturation or low transferrin saturation with low-normal ferritin (>20 mg/L) 2
When Ferritin Results Are Equivocal
When ferritin lies between 45–150 µg/L with elevated inflammatory markers (e.g., CRP), measure transferrin saturation, soluble transferrin receptor, or reticulocyte hemoglobin to confirm iron deficiency. 1 Remember that ferritin is an acute-phase reactant and may be falsely elevated in inflammatory states. 1
Ferritin >150 µg/L essentially excludes absolute iron deficiency, even with inflammation present. 1 In this scenario, hemoglobin electrophoresis should be performed to rule out thalassemia and other hemoglobinopathies, particularly in patients of Mediterranean, African, Middle Eastern, or Southeast Asian descent. 1
Investigation for Underlying Cause
Gastrointestinal Evaluation
Gastro-intestinal evaluation is warranted at any anemia severity when iron deficiency is present, with urgency increasing as anemia worsens because the risk of serious GI pathology (including malignancy) rises. 1 Both upper and lower endoscopy are typically indicated in adults with confirmed iron-deficiency anemia. 1
Specific testing should include:
- Testing for Helicobacter pylori 1
- Celiac disease screening 1
- Evaluation for other sources of GI blood loss 1
Additional History and Assessment
- Dietary iron intake review and referral to nutrition counseling to address possible insufficient intake 1
- Assessment of menstrual losses in individuals with menstrual blood loss potential 1
- Medication review to identify drugs that impair iron absorption (proton pump inhibitors, H2 blockers) or cause GI bleeding (NSAIDs, anticoagulants) 1
Treatment Strategy
Oral Iron Therapy (First-Line)
Oral iron is the first-line therapy for iron-deficiency anemia unless contraindicated. 1 Ferrous salts (sulfate, fumarate, gluconate) are reasonable first-choice formulations; no single preparation has demonstrated superiority. 1
Iron absorption is optimal on an empty stomach, but taking the dose with meals can improve tolerability if side effects occur. 1 Co-administration with approximately 500 mg vitamin C enhances absorption. 1
Recent evidence suggests that intermittent dosing is as effective as daily or twice-daily dosing with fewer side effects. 3
Monitoring Response
A rise in hemoglobin of ≥10 g/L within 2 weeks strongly suggests absolute iron deficiency, even when baseline iron studies are equivocal. 1 This therapeutic trial can serve as both diagnostic confirmation and treatment.
Intravenous Iron (Second-Line)
Intravenous iron should be considered for patients with:
- Severe deficiency 1
- Poor oral tolerance 1
- Malabsorption conditions 1
- Inadequate response to oral therapy 1
Specific populations that may benefit from initial IV iron include those with inflammatory bowel disease, celiac disease with poor dietary adherence, or heart failure. 1 With contemporary formulations, allergic reactions are rare. 3
Critical Pitfalls to Avoid
Do not rely solely on MCV and MCH; their diagnostic sensitivity declines in chronic disease, thalassemia, and vitamin B12/folate deficiency. 1 Studies show that more than 50% of women with documented iron deficiency were neither anemic nor microcytic at diagnosis. 4
Do not omit GI investigation in men or post-menopausal women, even with mild anemia, because colorectal cancer can present with any degree of iron-deficiency anemia. 1
Do not accept a "normal" ferritin level at face value in inflammatory states; it may be falsely elevated. 1
Do not pursue unnecessary GI workup when hemoglobin electrophoresis confirms thalassemia trait in patients with appropriate ethnic background and normal iron studies. 1
Do not assume normal CBC parameters exclude iron depletion; individuals with normal RBC count, hemoglobin, hematocrit, MCV, and MCHC may still have reduced serum iron and ferritin. 5